{"transactions":[{"id":1191926,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":81565,"kind":"person","name":"Millar Kerri-Ann","position":1,"cik":"0001739126","reported_name":"Millar Kerri-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-25T20:00:10.000Z","date":"2025-03-21","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option becomes exercisable in eight equal semi-annual installments beginning on September 21, 2025."}],"balance_after":200000,"derivative":{"exercise_price":0.99,"expiration_date":"2035-03-20","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000950170-25-044348","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000095017025044348/ownership.xml","form_type":"4"}},{"id":1486108,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":81565,"kind":"person","name":"Millar Kerri-Ann","position":1,"cik":"0001739126","reported_name":"Millar Kerri-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-06-07T20:00:02.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option becomes exercisable in eight equal semi-annual installments beginning on December 5, 2024."}],"balance_after":60000,"derivative":{"exercise_price":1.65,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000950170-24-070559","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000095017024070559/ownership.xml","form_type":"4"}},{"id":1585939,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":81565,"kind":"person","name":"Millar Kerri-Ann","position":1,"cik":"0001739126","reported_name":"Millar Kerri-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-08T21:00:12.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option becomes exercisable in eight equal semi-annual installments beginning on September 6, 2024."}],"balance_after":250000,"derivative":{"exercise_price":1.94,"expiration_date":"2034-03-05","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0000950170-24-028612","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000095017024028612/ownership.xml","form_type":"4"}},{"id":1823397,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":81565,"kind":"person","name":"Millar Kerri-Ann","position":1,"cik":"0001739126","reported_name":"Millar Kerri-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2023-07-25T16:31:14.000Z","date":"2023-07-21","kind":"grant","planned":false,"acquired":true,"shares":113000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option grant becomes exercisable in twenty four equal monthly installments beginning on August 21, 2023."}],"balance_after":113000,"derivative":{"exercise_price":4.2,"expiration_date":"2033-07-20","underlying":"Common Stock","underlying_shares":113000},"source":{"system":"sec-edgar","filing":"0001209191-23-043277","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919123043277/doc4.xml","form_type":"4"}},{"id":2002814,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":81565,"kind":"person","name":"Millar Kerri-Ann","position":1,"cik":"0001739126","reported_name":"Millar Kerri-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-21T21:58:08.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":124000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option becomes exercisable in eight equal semi-annual installments beginning on August 16, 2023."}],"balance_after":124000,"derivative":{"exercise_price":3.21,"expiration_date":"2033-02-15","underlying":"Common Stock","underlying_shares":124000},"source":{"system":"sec-edgar","filing":"0001209191-23-011245","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919123011245/doc4.xml","form_type":"4"}},{"id":2175745,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":81565,"kind":"person","name":"Millar Kerri-Ann","position":1,"cik":"0001739126","reported_name":"Millar Kerri-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2022-08-23T20:03:38.000Z","date":"2022-08-21","kind":"exercise","acquired":false,"shares":6667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit award represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents a restricted stock unit award granted on August 21, 2020. The restricted stock units vest in three equal annual installments beginning on August 21, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents a restricted stock unit award granted on August 21, 2020. The restricted stock units vest in three equal annual installments beginning on August 21, 2020."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6667},"source":{"system":"sec-edgar","filing":"0001209191-22-047161","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919122047161/doc4.xml","form_type":"4"}},{"id":2175744,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":81565,"kind":"person","name":"Millar Kerri-Ann","position":1,"cik":"0001739126","reported_name":"Millar Kerri-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2022-08-23T20:03:38.000Z","date":"2022-08-22","kind":"tax_withholding","acquired":false,"shares":2828,"price":3.05,"value":8625.4,"ownership":{"direct":true},"balance_after":14311,"source":{"system":"sec-edgar","filing":"0001209191-22-047161","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919122047161/doc4.xml","form_type":"4"}},{"id":2175743,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":81565,"kind":"person","name":"Millar Kerri-Ann","position":1,"cik":"0001739126","reported_name":"Millar Kerri-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2022-08-23T20:03:38.000Z","date":"2022-08-21","kind":"exercise","acquired":true,"shares":6667,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received upon vesting of a restricted stock unit award"},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock received upon vesting of a restricted stock unit award"}],"balance_after":17139,"source":{"system":"sec-edgar","filing":"0001209191-22-047161","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919122047161/doc4.xml","form_type":"4"}},{"id":2314895,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":81565,"kind":"person","name":"Millar Kerri-Ann","position":1,"cik":"0001739126","reported_name":"Millar Kerri-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-29T20:05:00.000Z","date":"2022-03-25","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"2. This stock option grant becomes exercisable in eight equal semi-annual installments beginning September 25, 2022."}],"balance_after":10000,"derivative":{"exercise_price":5.01,"expiration_date":"2032-03-24","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-22-021446","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919122021446/doc4.xml","form_type":"4"}},{"id":2314894,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":81565,"kind":"person","name":"Millar Kerri-Ann","position":1,"cik":"0001739126","reported_name":"Millar Kerri-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-29T20:05:00.000Z","date":"2022-02-09","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1. This stock option grant becomes exercisable in eight equal semi-annual installments beginning August 9, 2022."}],"balance_after":85000,"derivative":{"exercise_price":6.91,"expiration_date":"2032-02-08","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001209191-22-021446","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919122021446/doc4.xml","form_type":"4"}},{"id":2547928,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":81565,"kind":"person","name":"Millar Kerri-Ann","position":1,"cik":"0001739126","reported_name":"Millar Kerri-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2021-10-05T23:21:54.000Z","date":"2021-10-01","kind":"exercise","acquired":false,"shares":1251,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests in eight equal semi-annual installments beginning March 25, 2018."}],"balance_after":53749,"derivative":{"exercise_price":7.5,"expiration_date":"2024-12-27","underlying":"Common Stock","underlying_shares":1251},"source":{"system":"sec-edgar","filing":"0001209191-21-059698","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919121059698/doc4.xml","form_type":"4"}},{"id":2547927,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":81565,"kind":"person","name":"Millar Kerri-Ann","position":1,"cik":"0001739126","reported_name":"Millar Kerri-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2021-10-05T23:21:54.000Z","date":"2021-08-23","kind":"exercise","acquired":false,"shares":6667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit award represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Represents a restricted stock unit award granted on August 21, 2020. The restricted stock units vest in three equal annual installments beginning on August 21, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Represents a restricted stock unit award granted on August 21, 2020. The restricted stock units vest in three equal annual installments beginning on August 21, 2020."}],"balance_after":6667,"derivative":{"underlying":"Common Stock","underlying_shares":6667},"source":{"system":"sec-edgar","filing":"0001209191-21-059698","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919121059698/doc4.xml","form_type":"4"}},{"id":2547926,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":81565,"kind":"person","name":"Millar Kerri-Ann","position":1,"cik":"0001739126","reported_name":"Millar Kerri-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2021-10-05T23:21:54.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":1251,"price":14.2149,"value":17782.8399,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.01 to $14.46, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc., any security holder of Cue Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":10472,"source":{"system":"sec-edgar","filing":"0001209191-21-059698","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919121059698/doc4.xml","form_type":"4"}},{"id":2547925,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":81565,"kind":"person","name":"Millar Kerri-Ann","position":1,"cik":"0001739126","reported_name":"Millar Kerri-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2021-10-05T23:21:54.000Z","date":"2021-10-01","kind":"exercise","acquired":true,"shares":1251,"price":7.5,"value":9382.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2021."}],"balance_after":11723,"source":{"system":"sec-edgar","filing":"0001209191-21-059698","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919121059698/doc4.xml","form_type":"4"}},{"id":2547924,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":81565,"kind":"person","name":"Millar Kerri-Ann","position":1,"cik":"0001739126","reported_name":"Millar Kerri-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2021-10-05T23:21:54.000Z","date":"2021-08-23","kind":"tax_withholding","acquired":false,"shares":1961,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10472,"source":{"system":"sec-edgar","filing":"0001209191-21-059698","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919121059698/doc4.xml","form_type":"4"}},{"id":2547923,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":81565,"kind":"person","name":"Millar Kerri-Ann","position":1,"cik":"0001739126","reported_name":"Millar Kerri-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2021-10-05T23:21:54.000Z","date":"2021-08-23","kind":"exercise","acquired":true,"shares":6667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received upon vesting of a restricted stock unit award."}],"balance_after":12433,"source":{"system":"sec-edgar","filing":"0001209191-21-059698","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919121059698/doc4.xml","form_type":"4"}},{"id":2862317,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":81565,"kind":"person","name":"Millar Kerri-Ann","position":1,"cik":"0001739126","reported_name":"Millar Kerri-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-12T22:43:42.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option grant becomes exercisable in eight equal semi-annual installments beginning August 10, 2021."}],"balance_after":70000,"derivative":{"exercise_price":15.55,"expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0000899243-21-006354","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000089924321006354/doc4.xml","form_type":"4"}},{"id":3047332,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":81565,"kind":"person","name":"Millar Kerri-Ann","position":1,"cik":"0001739126","reported_name":"Millar Kerri-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Units","published_at":"2020-08-25T20:12:29.000Z","date":"2020-08-21","kind":"exercise","acquired":false,"shares":6666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit award represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents a restricted stock unit award granted on August 21, 2020. The restricted stock units vest in three equal annual installments beginning on August 21, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Represents a restricted stock unit award granted on August 21, 2020. The restricted stock units vest in three equal annual installments beginning on August 21, 2020."}],"balance_after":13334,"derivative":{"underlying":"Common Stock","underlying_shares":6666},"source":{"system":"sec-edgar","filing":"0001209191-20-048212","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919120048212/doc4.xml","form_type":"4"}},{"id":3047331,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":81565,"kind":"person","name":"Millar Kerri-Ann","position":1,"cik":"0001739126","reported_name":"Millar Kerri-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Units","published_at":"2020-08-25T20:12:29.000Z","date":"2020-08-21","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit award represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents a restricted stock unit award granted on August 21, 2020. The restricted stock units vest in three equal annual installments beginning on August 21, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Represents a restricted stock unit award granted on August 21, 2020. The restricted stock units vest in three equal annual installments beginning on August 21, 2020."}],"balance_after":20000,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-048212","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919120048212/doc4.xml","form_type":"4"}},{"id":3047330,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":81565,"kind":"person","name":"Millar Kerri-Ann","position":1,"cik":"0001739126","reported_name":"Millar Kerri-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (right to buy)","published_at":"2020-08-25T20:12:29.000Z","date":"2020-08-21","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option grant becomes exercisable in eight equal semi-annual installments beginning February 21, 2021."}],"balance_after":65000,"derivative":{"exercise_price":19.87,"expiration_date":"2030-08-21","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-20-048212","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919120048212/doc4.xml","form_type":"4"}},{"id":3047329,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":81565,"kind":"person","name":"Millar Kerri-Ann","position":1,"cik":"0001739126","reported_name":"Millar Kerri-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-08-25T20:12:29.000Z","date":"2020-08-24","kind":"tax_withholding","acquired":false,"shares":1900,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5766,"source":{"system":"sec-edgar","filing":"0001209191-20-048212","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919120048212/doc4.xml","form_type":"4"}},{"id":3047328,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":81565,"kind":"person","name":"Millar Kerri-Ann","position":1,"cik":"0001739126","reported_name":"Millar Kerri-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-08-25T20:12:29.000Z","date":"2020-08-21","kind":"exercise","acquired":true,"shares":6666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received upon vesting of a restricted stock unit award."}],"balance_after":7666,"source":{"system":"sec-edgar","filing":"0001209191-20-048212","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919120048212/doc4.xml","form_type":"4"}},{"id":3276171,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":81565,"kind":"person","name":"Millar Kerri-Ann","position":1,"cik":"0001739126","reported_name":"Millar Kerri-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP-Finance"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-12T21:52:45.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option grant becomes exercisable in eight equal semi-annual installments beginning August 5, 2020."}],"balance_after":30000,"derivative":{"exercise_price":16.26,"expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-20-008809","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919120008809/doc4.xml","form_type":"4"}},{"id":3603626,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":81565,"kind":"person","name":"Millar Kerri-Ann","position":1,"cik":"0001739126","reported_name":"Millar Kerri-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP-Finance"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-08T21:09:47.000Z","date":"2019-03-06","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option grant becomes exercisable in eight equal semi-annual installments beginning September 6, 2019."}],"balance_after":30000,"derivative":{"exercise_price":6.42,"expiration_date":"2029-03-06","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-19-018083","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919119018083/doc4.xml","form_type":"4"}},{"id":3830186,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":81565,"kind":"person","name":"Millar Kerri-Ann","position":1,"cik":"0001739126","reported_name":"Millar Kerri-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP-Finance"}}],"security":"Common Stock","published_at":"2018-08-29T22:39:10.000Z","date":"2018-08-29","kind":"purchase","acquired":true,"shares":1000,"price":8.48,"value":8480.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001209191-18-048862","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919118048862/doc4.xml","form_type":"4"}},{"id":3861268,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":81565,"kind":"person","name":"Millar Kerri-Ann","position":1,"cik":"0001739126","reported_name":"Millar Kerri-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP-Finance"}}],"security":"Stock Option (right to buy)","published_at":"2018-07-25T20:50:45.000Z","date":"2018-07-23","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option grant becomes exercisable in eight semi-annual installments beginning July 23, 2018."}],"balance_after":50000,"derivative":{"exercise_price":11.54,"expiration_date":"2025-07-23","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-18-043907","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919118043907/doc4.xml","form_type":"4"}}]}